NEW YORK (GenomeWeb) – Phase Genomics said today that it has received a two-year, $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to develop an affordable, high-throughput Hi-C kit and computational analysis platform for microbiome research and discovery.

The firm said it had previously received a Phase I SBIR grant from the NIAID as well as an investment from WRF Capital and Congruent Ventures to develop the platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.